Search results for the GEO ID: GSE40261  |
(Click on the check boxes provided under "Select for analysis", to initiate grouping) |
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down) |
|
GSM ID | GPL ID |
Select for analysis |
Title |
Source name |
Description |
Characteristics |
GSM989360 | GPL1261 |
|
Control 1
|
Liver
|
tissue: liver
treatment: Scramble ASO
strain: BALB/c
gender: female
|
Scramble ASO 1
|
| Sample_geo_accession | GSM989360
| | Sample_status | Public on Aug 22 2012
| | Sample_submission_date | Aug 21 2012
| | Sample_last_update_date | Aug 22 2012
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Mus musculus
| | Sample_taxid_ch1 | 10090
| | Sample_treatment_protocol_ch1 | Adult BALB/c female mice were injected intraperitoneally with a single dose at 20 mg per kg of antisense oligonucleotide either against miR-29a (5’-TAACCGATTTCAGATGGTGCTA-3’) or against a scrambled sequence (5’-TCATTGGCATGTACCATGCAGCT-3’ Antisense oligonucleotides contained 2’-O-methoxyethyl (2’-MOE), 2’-flouro (2’-F) 2'-alpha-flouro units with a phosphorothioate backbone (Regulus Therapeutics). Six days following the injection, liver was isolated
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Total RNA was purified from liver using the mirVana™ miRNA Isolation Kit (Ambion) according to the manufacturer’s instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | standard Affymetrix protocol
| | Sample_hyb_protocol | standard Affymetrix protocol
| | Sample_scan_protocol | standard Affymetrix protocol
| | Sample_data_processing | Partek, using gcrma algorithm
| | Sample_platform_id | GPL1261
| | Sample_contact_name | Joshua,,Friedman
| | Sample_contact_email | friedmaj@mail.med.upenn.edu
| | Sample_contact_department | Pediatrics
| | Sample_contact_institute | University of Pennsylvania School of Medicine
| | Sample_contact_address | ARC 1007B, 3615 Civic Center Blvd.
| | Sample_contact_city | Philadelphia
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19104
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM989nnn/GSM989360/suppl/GSM989360_1162_Mo430_2_102010_Mouse430_2_.CEL.gz
| | Sample_series_id | GSE40261
| | Sample_data_row_count | 45101
| | |
|
GSM989361 | GPL1261 |
|
Control 2
|
Liver
|
tissue: liver
treatment: Scramble ASO
strain: BALB/c
gender: female
|
Scramble ASO 2
|
| Sample_geo_accession | GSM989361
| | Sample_status | Public on Aug 22 2012
| | Sample_submission_date | Aug 21 2012
| | Sample_last_update_date | Aug 22 2012
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Mus musculus
| | Sample_taxid_ch1 | 10090
| | Sample_treatment_protocol_ch1 | Adult BALB/c female mice were injected intraperitoneally with a single dose at 20 mg per kg of antisense oligonucleotide either against miR-29a (5’-TAACCGATTTCAGATGGTGCTA-3’) or against a scrambled sequence (5’-TCATTGGCATGTACCATGCAGCT-3’ Antisense oligonucleotides contained 2’-O-methoxyethyl (2’-MOE), 2’-flouro (2’-F) 2'-alpha-flouro units with a phosphorothioate backbone (Regulus Therapeutics). Six days following the injection, liver was isolated
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Total RNA was purified from liver using the mirVana™ miRNA Isolation Kit (Ambion) according to the manufacturer’s instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | standard Affymetrix protocol
| | Sample_hyb_protocol | standard Affymetrix protocol
| | Sample_scan_protocol | standard Affymetrix protocol
| | Sample_data_processing | Partek, using gcrma algorithm
| | Sample_platform_id | GPL1261
| | Sample_contact_name | Joshua,,Friedman
| | Sample_contact_email | friedmaj@mail.med.upenn.edu
| | Sample_contact_department | Pediatrics
| | Sample_contact_institute | University of Pennsylvania School of Medicine
| | Sample_contact_address | ARC 1007B, 3615 Civic Center Blvd.
| | Sample_contact_city | Philadelphia
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19104
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM989nnn/GSM989361/suppl/GSM989361_1163_Mo430_2_102010_Mouse430_2_.CEL.gz
| | Sample_series_id | GSE40261
| | Sample_data_row_count | 45101
| | |
|
GSM989362 | GPL1261 |
|
Control 3
|
Liver
|
tissue: liver
treatment: Scramble ASO
strain: BALB/c
gender: female
|
Scramble ASO 3
|
| Sample_geo_accession | GSM989362
| | Sample_status | Public on Aug 22 2012
| | Sample_submission_date | Aug 21 2012
| | Sample_last_update_date | Aug 22 2012
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Mus musculus
| | Sample_taxid_ch1 | 10090
| | Sample_treatment_protocol_ch1 | Adult BALB/c female mice were injected intraperitoneally with a single dose at 20 mg per kg of antisense oligonucleotide either against miR-29a (5’-TAACCGATTTCAGATGGTGCTA-3’) or against a scrambled sequence (5’-TCATTGGCATGTACCATGCAGCT-3’ Antisense oligonucleotides contained 2’-O-methoxyethyl (2’-MOE), 2’-flouro (2’-F) 2'-alpha-flouro units with a phosphorothioate backbone (Regulus Therapeutics). Six days following the injection, liver was isolated
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Total RNA was purified from liver using the mirVana™ miRNA Isolation Kit (Ambion) according to the manufacturer’s instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | standard Affymetrix protocol
| | Sample_hyb_protocol | standard Affymetrix protocol
| | Sample_scan_protocol | standard Affymetrix protocol
| | Sample_data_processing | Partek, using gcrma algorithm
| | Sample_platform_id | GPL1261
| | Sample_contact_name | Joshua,,Friedman
| | Sample_contact_email | friedmaj@mail.med.upenn.edu
| | Sample_contact_department | Pediatrics
| | Sample_contact_institute | University of Pennsylvania School of Medicine
| | Sample_contact_address | ARC 1007B, 3615 Civic Center Blvd.
| | Sample_contact_city | Philadelphia
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19104
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM989nnn/GSM989362/suppl/GSM989362_1164_Mo430_2_102010_Mouse430_2_.CEL.gz
| | Sample_series_id | GSE40261
| | Sample_data_row_count | 45101
| | |
|
GSM989363 | GPL1261 |
|
Control 4
|
Liver
|
tissue: liver
treatment: Scramble ASO
strain: BALB/c
gender: female
|
Scramble ASO 4
|
| Sample_geo_accession | GSM989363
| | Sample_status | Public on Aug 22 2012
| | Sample_submission_date | Aug 21 2012
| | Sample_last_update_date | Aug 22 2012
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Mus musculus
| | Sample_taxid_ch1 | 10090
| | Sample_treatment_protocol_ch1 | Adult BALB/c female mice were injected intraperitoneally with a single dose at 20 mg per kg of antisense oligonucleotide either against miR-29a (5’-TAACCGATTTCAGATGGTGCTA-3’) or against a scrambled sequence (5’-TCATTGGCATGTACCATGCAGCT-3’ Antisense oligonucleotides contained 2’-O-methoxyethyl (2’-MOE), 2’-flouro (2’-F) 2'-alpha-flouro units with a phosphorothioate backbone (Regulus Therapeutics). Six days following the injection, liver was isolated
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Total RNA was purified from liver using the mirVana™ miRNA Isolation Kit (Ambion) according to the manufacturer’s instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | standard Affymetrix protocol
| | Sample_hyb_protocol | standard Affymetrix protocol
| | Sample_scan_protocol | standard Affymetrix protocol
| | Sample_data_processing | Partek, using gcrma algorithm
| | Sample_platform_id | GPL1261
| | Sample_contact_name | Joshua,,Friedman
| | Sample_contact_email | friedmaj@mail.med.upenn.edu
| | Sample_contact_department | Pediatrics
| | Sample_contact_institute | University of Pennsylvania School of Medicine
| | Sample_contact_address | ARC 1007B, 3615 Civic Center Blvd.
| | Sample_contact_city | Philadelphia
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19104
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM989nnn/GSM989363/suppl/GSM989363_1165_Mo430_2_102010_Mouse430_2_.CEL.gz
| | Sample_series_id | GSE40261
| | Sample_data_row_count | 45101
| | |
|
GSM989364 | GPL1261 |
|
Anti-29a 1
|
Liver
|
tissue: liver
treatment: MiR-29a ASO
strain: BALB/c
gender: female
|
MiR-29a ASO 1
|
| Sample_geo_accession | GSM989364
| | Sample_status | Public on Aug 22 2012
| | Sample_submission_date | Aug 21 2012
| | Sample_last_update_date | Aug 22 2012
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Mus musculus
| | Sample_taxid_ch1 | 10090
| | Sample_treatment_protocol_ch1 | Adult BALB/c female mice were injected intraperitoneally with a single dose at 20 mg per kg of antisense oligonucleotide either against miR-29a (5’-TAACCGATTTCAGATGGTGCTA-3’) or against a scrambled sequence (5’-TCATTGGCATGTACCATGCAGCT-3’ Antisense oligonucleotides contained 2’-O-methoxyethyl (2’-MOE), 2’-flouro (2’-F) 2'-alpha-flouro units with a phosphorothioate backbone (Regulus Therapeutics). Six days following the injection, liver was isolated
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Total RNA was purified from liver using the mirVana™ miRNA Isolation Kit (Ambion) according to the manufacturer’s instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | standard Affymetrix protocol
| | Sample_hyb_protocol | standard Affymetrix protocol
| | Sample_scan_protocol | standard Affymetrix protocol
| | Sample_data_processing | Partek, using gcrma algorithm
| | Sample_platform_id | GPL1261
| | Sample_contact_name | Joshua,,Friedman
| | Sample_contact_email | friedmaj@mail.med.upenn.edu
| | Sample_contact_department | Pediatrics
| | Sample_contact_institute | University of Pennsylvania School of Medicine
| | Sample_contact_address | ARC 1007B, 3615 Civic Center Blvd.
| | Sample_contact_city | Philadelphia
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19104
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM989nnn/GSM989364/suppl/GSM989364_1166_Mo430_2_102010_Mouse430_2_.CEL.gz
| | Sample_series_id | GSE40261
| | Sample_data_row_count | 45101
| | |
|
GSM989365 | GPL1261 |
|
Anti-29a 2
|
Liver
|
tissue: liver
treatment: MiR-29a ASO
strain: BALB/c
gender: female
|
MiR-29a ASO 2
|
| Sample_geo_accession | GSM989365
| | Sample_status | Public on Aug 22 2012
| | Sample_submission_date | Aug 21 2012
| | Sample_last_update_date | Aug 22 2012
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Mus musculus
| | Sample_taxid_ch1 | 10090
| | Sample_treatment_protocol_ch1 | Adult BALB/c female mice were injected intraperitoneally with a single dose at 20 mg per kg of antisense oligonucleotide either against miR-29a (5’-TAACCGATTTCAGATGGTGCTA-3’) or against a scrambled sequence (5’-TCATTGGCATGTACCATGCAGCT-3’ Antisense oligonucleotides contained 2’-O-methoxyethyl (2’-MOE), 2’-flouro (2’-F) 2'-alpha-flouro units with a phosphorothioate backbone (Regulus Therapeutics). Six days following the injection, liver was isolated
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Total RNA was purified from liver using the mirVana™ miRNA Isolation Kit (Ambion) according to the manufacturer’s instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | standard Affymetrix protocol
| | Sample_hyb_protocol | standard Affymetrix protocol
| | Sample_scan_protocol | standard Affymetrix protocol
| | Sample_data_processing | Partek, using gcrma algorithm
| | Sample_platform_id | GPL1261
| | Sample_contact_name | Joshua,,Friedman
| | Sample_contact_email | friedmaj@mail.med.upenn.edu
| | Sample_contact_department | Pediatrics
| | Sample_contact_institute | University of Pennsylvania School of Medicine
| | Sample_contact_address | ARC 1007B, 3615 Civic Center Blvd.
| | Sample_contact_city | Philadelphia
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19104
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM989nnn/GSM989365/suppl/GSM989365_1167_Mo430_2_102010_Mouse430_2_.CEL.gz
| | Sample_series_id | GSE40261
| | Sample_data_row_count | 45101
| | |
|
GSM989366 | GPL1261 |
|
Anti-29a 3
|
Liver
|
tissue: liver
treatment: MiR-29a ASO
strain: BALB/c
gender: female
|
MiR-29a ASO 3
|
| Sample_geo_accession | GSM989366
| | Sample_status | Public on Aug 22 2012
| | Sample_submission_date | Aug 21 2012
| | Sample_last_update_date | Aug 22 2012
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Mus musculus
| | Sample_taxid_ch1 | 10090
| | Sample_treatment_protocol_ch1 | Adult BALB/c female mice were injected intraperitoneally with a single dose at 20 mg per kg of antisense oligonucleotide either against miR-29a (5’-TAACCGATTTCAGATGGTGCTA-3’) or against a scrambled sequence (5’-TCATTGGCATGTACCATGCAGCT-3’ Antisense oligonucleotides contained 2’-O-methoxyethyl (2’-MOE), 2’-flouro (2’-F) 2'-alpha-flouro units with a phosphorothioate backbone (Regulus Therapeutics). Six days following the injection, liver was isolated
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Total RNA was purified from liver using the mirVana™ miRNA Isolation Kit (Ambion) according to the manufacturer’s instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | standard Affymetrix protocol
| | Sample_hyb_protocol | standard Affymetrix protocol
| | Sample_scan_protocol | standard Affymetrix protocol
| | Sample_data_processing | Partek, using gcrma algorithm
| | Sample_platform_id | GPL1261
| | Sample_contact_name | Joshua,,Friedman
| | Sample_contact_email | friedmaj@mail.med.upenn.edu
| | Sample_contact_department | Pediatrics
| | Sample_contact_institute | University of Pennsylvania School of Medicine
| | Sample_contact_address | ARC 1007B, 3615 Civic Center Blvd.
| | Sample_contact_city | Philadelphia
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19104
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM989nnn/GSM989366/suppl/GSM989366_1168_Mo430_2_102010_Mouse430_2_.CEL.gz
| | Sample_series_id | GSE40261
| | Sample_data_row_count | 45101
| | |
|
GSM989367 | GPL1261 |
|
Anti-29a 4
|
Liver
|
tissue: liver
treatment: MiR-29a ASO
strain: BALB/c
gender: female
|
MiR-29a ASO 4
|
| Sample_geo_accession | GSM989367
| | Sample_status | Public on Aug 22 2012
| | Sample_submission_date | Aug 21 2012
| | Sample_last_update_date | Aug 22 2012
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Mus musculus
| | Sample_taxid_ch1 | 10090
| | Sample_treatment_protocol_ch1 | Adult BALB/c female mice were injected intraperitoneally with a single dose at 20 mg per kg of antisense oligonucleotide either against miR-29a (5’-TAACCGATTTCAGATGGTGCTA-3’) or against a scrambled sequence (5’-TCATTGGCATGTACCATGCAGCT-3’ Antisense oligonucleotides contained 2’-O-methoxyethyl (2’-MOE), 2’-flouro (2’-F) 2'-alpha-flouro units with a phosphorothioate backbone (Regulus Therapeutics). Six days following the injection, liver was isolated
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Total RNA was purified from liver using the mirVana™ miRNA Isolation Kit (Ambion) according to the manufacturer’s instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | standard Affymetrix protocol
| | Sample_hyb_protocol | standard Affymetrix protocol
| | Sample_scan_protocol | standard Affymetrix protocol
| | Sample_data_processing | Partek, using gcrma algorithm
| | Sample_platform_id | GPL1261
| | Sample_contact_name | Joshua,,Friedman
| | Sample_contact_email | friedmaj@mail.med.upenn.edu
| | Sample_contact_department | Pediatrics
| | Sample_contact_institute | University of Pennsylvania School of Medicine
| | Sample_contact_address | ARC 1007B, 3615 Civic Center Blvd.
| | Sample_contact_city | Philadelphia
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19104
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM989nnn/GSM989367/suppl/GSM989367_1169_Mo430_2_102010_Mouse430_2_.CEL.gz
| | Sample_series_id | GSE40261
| | Sample_data_row_count | 45101
| | |
|
| |
| |
Make groups for comparisons |
(2 groups will be compared at a time) |
|
| Select GSMs and click on "Add groups" |
Enter the group name here: |
|
|
|
